Kalled Susan 4
4 · Compass Therapeutics, Inc. · Filed Feb 18, 2022
Insider Transaction Report
Form 4
Kalled Susan
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-17+60,000→ 60,000 totalExercise: $2.52Exp: 2032-02-16→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The options vest over 48 substantially equal monthly installments starting 03/17/2022